Oritezomib

Main information

  • Trade name:
  • Oritezomib 3.5 mg Lyophilized Powder For Solution For Injection (Sc/ Iv)
  • Dosage:
  • 3.5 mg
  • Pharmaceutical form:
  • Lyophilized Powder For Solution For Injection (Sc/Iv)
  • Units in package:
  • 10mL Colorless Type I glass vial with bromobutyl rubber closure and aluminum flip-off seal (box of 1's)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Oncomed Manufacturing

Documents

Localization

  • Available in:
  • Oritezomib 3.5 mg Lyophilized Powder For Solution For Injection (Sc/Iv)
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DR-XY46179
  • Authorization date:
  • 28-11-2022
  • Last update:
  • 15-01-2018